Wuhan Desheng Biochemical Technology Co., Ltd

Hubei Xindesheng Material Technology Co., Ltd.'s Huanggang New Production Base Construction Another Good News - As of now, all production equipment in the new factory has been installed in place, and key processes such as flaw detection, pressure leakage testing, and single machine debugging have been completed and accepted. The automatic control system joint debugging and testing will be fully completed. The project is steadily advancing with high standards and high quality, and is expected to officially enter the trial production stage in the near future. Huanggang New Factory is the second R&D and production base established by Hubei Xindesheng Material Technology Co., Ltd. after the Gedian base. The project covers an area of approximately 80 acres. After the new factory is fully completed and put into operation, the company's total production capacity will double, providing a solid guarantee for the large-scale and high-quality production of core products such as biological buffering agents and carbomers. The equipment installation has been fully completed and the key processes have been passed All production equipment installation is in place. All production equipment in the new factory, including customized large reaction vessels, distillation towers, drying equipment, packaging lines, etc., have been installed and fixed. The equipment selection fully considers the strict requirements of biological buffer products for high purity, low impurities, and batch consistency. The core equipment is customized design, which can meet the flexible production needs of multiple product lines such as Tris, Hepes,caps, mops, carbomer, and blood separation gel. Flaw detection, pressure leakage testing, and single machine debugging passed all at once. After the equipment installation was completed, the project team strictly followed the chemical project construction specifications and completed three key inspection processes in sequence: Ultrasonic testing: Conduct non-destructive testing on all pressure vessels and pressure pipelines, and ensure that all welds meet the quality standards; Pressure testing and leak detection: Conduct pressure testing and leak detection on the entire system, and ensure that the airtightness meets the design standards; Single machine debugging: Each device completes no-load and load tests separately, and all operating parameters meet the standards. The successful acceptance of the three major processes marks that the hardware facilities of the new factory have fully met the conditions for joint testing. The self-control system is about to complete the comprehensive upgrade of intelligent manufacturing through joint debugging All hardware installations of the self-control system have been completed. The automation control system of the new factory covers the complete production chain from raw material storage, precise feeding, reaction process control, temperature and pressure regulation to finished product packaging and delivery. The installation and wiring of all self-control equipment have been completed. The joint debugging and testing are about to end. At present, the joint debugging and testing of the self-control system has entered the final stage. After the joint debugging is completed, the entire production line will achieve full process automation operation, and operators can complete real-time monitoring and precise adjustment of the entire production process in the central control room. The construction of intelligent production lines will bring three major improvements: One is to improve efficiency. Automated control significantly reduces manual intervention, resulting in a more stable and efficient production rhythm. The second is the improvement of quality. Accurate process control effectively reduces fluctuations between batches, ensuring product consistency. The third is to enhance safety. The system has complete abnormal alarm and interlock protection functions, which can monitor key parameters such as temperature, pressure, and liquid level in real time, automatically handle abnormalities, and effectively prevent safety risks. The countdown to trial production is approaching, and the release of production capacity is just around the corner With the comprehensive completion of equipment installation and automatic control system debugging, the trial production of the new factory has entered the countdown stage. The trial production plan covers the entire process operation specifications, process parameter settings, quality control standards, safety emergency plans, and personnel training plans for feeding and testing. The remaining finishing work is expected to be completed in the near future. After the project is put into operation, the company will form a dual base collaborative production pattern of Gedian and Huanggang, and the total production capacity will achieve a leapfrog increase. The annual production capacity of 5000 tons can fully meet the sustained growth demand for high-end biological buffering agents in domestic and international markets. Continuously empowering the industry to assist in localization substitution Biological buffering agents are essential core materials for strategic emerging industries such as in vitro diagnostics (IVD), biopharmaceuticals, and new energy. For a long time, the high-end biological buffer market has relied to some extent on imports. The completion and operation of Hubei Xindesheng Huanggang New Factory will effectively enhance the independent supply capacity of domestic biological buffering agents. After the new factory is put into operation, the company's biological buffer product matrix will be further enriched, with a stable purity of over 99%, and customized indicators can be achieved according to customer application scenarios. The improvement of large-scale production capacity will also provide customers with more stable and efficient supply chain guarantees. In the future, Hubei Xindesheng Material Technology Co., Ltd. will continue to deepen its cultivation in the fields of biological buffering agents and IVD core raw materials, and continue to empower industry development with higher quality products and more professional services.

Recently, good news came from the Huanggang new production base of Hubei Xindesheng Material Technology Co., Ltd. - all equipment installation work in the new factory has been completed, and key processes such as flaw detection, pressure leakage testing, and single machine debugging have been successfully accepted. This marks the official transition of the project from the construction phase to the system integration debugging and trial production preparation phase, laying a solid foundation for the subsequent full line integration debugging and formal production. Hubei Xindesheng Huanggang New Production Base is located in the Chemical Industry Park of Huanggang High tech Zone, mainly engaged in the research and production of biological buffering agents and carbomer materials. The project covers an area of approximately 80 acres, with the construction of modern production workshops and related public and auxiliary engineering and environmental protection projects. It plans to develop high-end biological buffering agents such as Tris, Hepes, serum separation gel, as well as pharmaceutical and electronic new material products. After the new factory is fully built and put into operation, it will significantly expand the production capacity of biological buffering agents and IVD core raw materials. The company's scale production capacity, raw material quality control level, and large-scale order delivery ability will achieve a leapfrog improvement. All equipment installation is in place, and the key process has passed the acceptance inspection Equipment installation is the core process of chemical project construction. Since the equipment was installed on site, the project team has scientifically organized construction and coordinated progress to ensure that all work is efficiently completed according to the milestones. As of now, all production equipment in the new factory has been installed in place, and dozens of customized large-scale reaction vessels and related supporting equipment have been completed in place and fixed. After the installation of the equipment was completed, the project team immediately carried out systematic quality inspection work: Ultrasonic testing: Comprehensive non-destructive testing was conducted on key pressure bearing components such as pressure vessels and pressure pipelines. All welds and connections met the design standards and safety specifications, and the test results were all qualified. Pressure testing and leakage testing: Strict pressure testing and leakage detection were conducted on all pipeline systems and equipment to ensure that there are no hidden dangers of leakage throughout the production process, and the system's sealing meets the design specifications. Single machine debugging: Each device has completed no-load and load operation tests, and core parameters such as motor rotation, temperature control accuracy, mixing rate, and smooth feeding and discharging have all met the design requirements. The equipment is operating in good condition. The successful acceptance of the three key processes mentioned above signifies that the hardware facilities of the new factory are ready for joint testing. The installation of the self-control system is completed, and the joint debugging and testing are about to end At the same time as the hardware equipment is in place, the installation of the new factory's automation control system has also been fully completed. As the "nerve center" of modern chemical production, the self-control system covers the full process automation management from raw material feeding, reaction control, temperature and pressure regulation to finished product packaging. At present, the hardware installation, wiring, and system configuration of all self-control equipment have been completed. The joint debugging and testing work is about to be completed. After the completion of the joint debugging and testing, the entire production line will achieve an intelligent operation mode of "one click start stop, full process monitoring, abnormal alarm, and automatic adjustment", which not only greatly improves production efficiency, but also effectively ensures the consistency and stability between product batches - this is crucial for fine chemical products such as biological buffers that have strict requirements for purity and batch differences. The preparation of the trial production plan has been completed and the countdown to production has begun As a key link in the project's transition from construction to operation, the preparation of the trial production plan has been completed. The trial production plan covers the entire process operation specifications, process parameter settings, quality control standards, safety emergency plans, and personnel training plans for feeding and testing. In the process of formulating the plan, the technical team fully combined the performance parameters of the new equipment with the rich production experience accumulated by the company in the field of biological buffering agents over the years, and carried out refined design for each step of the operation. The finishing work mainly involves the final confirmation and approval process of some detailed parameters, and is expected to be completed in the near future. After the completion of the plan preparation, the project will officially enter the trial production stage, and the new factory will welcome the first batch of products to be produced offline. Leapfrog increase in production capacity helps to localize IVD raw materials The completion and operation of Huanggang New Factory is of great significance to Hubei Xindesheng and even the entire biological buffer industry. In terms of production capacity, after the new factory is put into operation, the annual production capacity of biological buffering agents and other products will reach 5000 tons, and the overall production capacity will be significantly increased. The enhancement of large-scale production capacity will effectively ensure the stable supply of large-scale orders from downstream customers. In terms of quality, the new factory is equipped with advanced automation control system and strict quality inspection system. The product purity can be stably controlled at over 99%, and the difference between batches can be controlled within 1%, which can better meet the increasing demand for high-end biological buffering agents in domestic and foreign markets. At the industry level, as an important component of IVD in vitro diagnostic core materials, the localization and substitution process of biological buffering agents is accelerating. The commissioning of the new Huanggang plant will further strengthen the domestic ability to independently supply biological buffering agents and help ensure the safety and stability of the industrial and supply chains. Please stay tuned for further updates on trial production and official production.

1, Get to know MOPSO - an important member of the Good's buffer family 3- (N-morpholino) - hydroxypropanesulfonic acid (MOPSO, CAS number 68399-77-9) is a high-quality zwitterionic biological buffering reagent with the molecular formula C ₇ H ₁ NO ₅ S and a molecular weight of 225.27. Its structure is similar to MOPS, except that there is an additional hydroxyl group at the C position in the propane region, which endows MOPSO with unique buffering properties. MOPSO belongs to the well-known "Good's buffer" family, with an effective pH buffering range of 6.2-7.6 and a pKa of 6.95 (25 ℃). This interval precisely covers the optimal reaction pH of the vast majority of clinical diagnostic enzymes (such as oxidases, esterases, peroxidases, etc.), making it an irreplaceable tool in enzymatic assay kits for in vitro diagnostics (IVD). Hubei Xindesheng Material Technology Co., Ltd. produces various types of biological buffer raw materials. MOPSO's core physical and chemical advantages: Strong buffering capacity: It has stable and powerful buffering capacity within the pH range of 6.5-7.5, perfectly adapting to physiological and enzymatic reaction environments; Excellent biocompatibility: no significant toxicity to bioactive components such as enzymes and antibodies, suitable for preparing liquid reagents; Low ion strength: contributes little to the ion strength of the reaction system, reducing interference; High compatibility with metal ions: does not chelate with common metal cofactors such as Ca ² ⁺ and Mg ² ⁺, ensuring the activity of metal dependent enzymes; Good water solubility: easily soluble in water, easy to prepare. 2, Typical application examples of MOPSO in enzymatic assay kits MOPSO has been widely used in various approved enzymatic detection kits, with the following representative cases: 2.1 Cholesterol Determination Kit (Enzyme Method) Cholesterol testing is a core component of blood lipid screening. Multiple cholesterol (CHOL) assay kits use MOPSO as the core buffer component, such as: Cholesterol determination kit (esterase peroxidase method): Reagent 1 contains MOPSO 50 mmol/L, lipoprotein esterase, p-hydroxybenzoic acid, peroxidase; Reagent 2 contains MOPSO 50 mmol/L, 4-aminoantipyrine, and cholesterol oxidase. Total cholesterol (TC/CHOL) assay kit (CE-CO-POD enzyme method): R1/R2 both contain MOPSO buffer, combined with MgCl ₂, DHBS, etc. MOPSO provides a stable pH environment for cholesterol oxidase and cholesterol esterase, ensuring enzyme activity and detection precision. 2.2 Glycated Albumin Assay Kit (Enzymatic Method) Glycated albumin (GA) reflects short-term blood glucose control levels. Representative reagent kits include: GA-L assay kit (enzymatic method) for measuring glycated albumin ratio: GA-R1 contains MOPSO, glycated amino acid oxidase (KAOD), 4-aminoantipyrine, albumin protease, etc; GA-R2 contains MOPSO, peroxidase TOOS. Glycated albumin assay kit (enzymatic method): R1 contains MOPSO 100 mmol/L, KAOD 12500 U/L, catalase; R2 contains MOPSO 100 mmol/L. High concentration MOPSO (100 mmol/L) provides precise pH protection for cascade reactions of multiple enzymes. 2.3 5 '- Nuclease Assay Kit (Enzymatic Method) 5 '- nucleotidase (5' - NT) is an important serum marker for liver and gallbladder diseases. The R1 and R2 of its assay kit (enzymatic method) are based on MOPSO (pH 7.6), combined with nucleotide phosphorylase, xanthine oxidase, peroxidase, etc., to achieve multi enzyme coupling detection. 2.4 Other enzyme assay kits MOPSO is also widely used in reagent kits for homocysteine detection (cyclic enzyme method), alpha amylase detection (IFCC method), low-density lipoprotein cholesterol determination (clearance method), and ultra sensitive C-reactive protein determination (immunoturbidimetric method), fully demonstrating its versatility and reliability. From cholesterol to glycosylated albumin, from 5 '- NT to homocysteine, MOPSO has become an indispensable buffering component in enzymatic assay kits due to its precise buffering range and excellent biocompatibility. In the next article, we will delve into the technical reasons and key indicators for selecting MOPSO for enzyme assay kits. Please stay tuned.

Why choose HEPES sodium salt for the flow cytometry kit The flow cytometry kit has extremely strict requirements for the buffer system, and the reason why HEPES sodium salt has become the preferred buffer in this field is mainly based on the following technical advantages. PH buffering range perfectly adapts to physiological and reaction conditions The effective buffering range of HEPES sodium salt is pH 6.8-8.2, with a pKa of 7.5 (25 ℃), highly matching physiological pH 7.36. The antigen antibody reaction and enzyme catalyzed luminescence reaction of the flow cytometry fluorescence luminescence method have good activity within this pH range. HEPES sodium salt can stabilize the system pH in the optimal range throughout the reaction process, ensuring high reaction efficiency. Not chelating metal ions to ensure the integrity of the reaction system Flow cytometry involves multiple metal ion dependent biological reaction steps, such as antigen antibody binding, enzyme catalyzed reactions, etc. HEPES sodium salt has extremely low metal ion binding ability and does not chelate key cofactors such as Mg ² ⁺, Ca ² ⁺, Mn ² ⁺, etc. In contrast, Tris and phosphate buffering agents have strong metal ion binding abilities, which may interfere with metal ion dependent enzymatic reactions. This characteristic makes HEPES sodium salt an ideal substitute for Tris and phosphates in research involving metal ions. High optical transparency, does not interfere with fluorescence detection The core detection signal of flow cytometry is fluorescence intensity. HEPES sodium salt has extremely low absorption in the visible and ultraviolet regions, and high optical transparency. This means that HEPES sodium salt itself does not produce background fluorescence or absorb target fluorescence signals, ensuring a higher detection signal-to-noise ratio. Strong chemical inertness, does not interfere with immune response HEPES, with its chemical inertness, temperature stability, and strong buffering capacity, is theoretically the best choice for biochemical compatibility. It can minimize the interference of the buffer solution itself on immune and enzymatic reactions, often resulting in better signal-to-noise ratio. This is crucial for pursuing in vitro diagnostic kits with high sensitivity and specificity. Low cytotoxicity, protects bioactive components The flow cytometry kit contains bioactive components such as antibodies, antigens, enzyme markers, etc., which have high requirements for the biocompatibility of the buffer system. The cytotoxicity of HEPES sodium salt is lower than that of traditional buffering agents such as Tris and phosphate, which can better protect the stability and activity of bioactive components in the kit. Suggestions for selection of HEPES sodium salt raw materials For manufacturers of flow cytometry kits, the quality of HEPES sodium salt raw materials directly affects the performance of the finished kit. It is recommended to focus on the following quality indicators when selecting raw materials: quality indicator Suggested requirements Instructions Main content ≥99.0% The higher the purity, the more stable the buffering capacity, and the better the batch Water solubility Completely dissolved, clear and transparent Ensure that the buffer solution is prepared without any residual particles heavy metal heavy metal ≤10ppm Metal ions may interfere with enzymatic reactions and fluorescence signals Absorbance(260nm/280nm) Low absorbance Reflect the content of organic impurities, accurately Dry weight loss ≤0.5% low moisture content, conducive to long-term storage Batch consistency Batch difference ≤ 1% Ensure stable performance of different batches of reagent kits   Hubei Xindesheng Material Technology Co., Ltd. has been specializing in the research and production of biological buffering agents for more than ten years. HEPES sodium salt products are strictly organized and produced according to the ISO 9001 quality management system, with a main content stable at over 99%. The content of metal ions and organic impurities is strictly controlled, which can meet the strict requirements of buffer raw materials in high-end application scenarios such as flow cytometry kits, cell culture media, and biopharmaceuticals. The company also provides various biological buffering agents such as Tris, Bicine, Caps, Mops, Taps, EPPS, and Carbopol series products, committed to providing high-quality core raw materials for the IVD in vitro diagnostic industry. Welcome all reagent kit research and production enterprises to call or write to request technical information and samples.